🇺🇸 FDA
Patent

US 12180251

Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders

granted A61KA61K31/485A61K31/515

Quick answer

US patent 12180251 (Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders) held by The Board of Regents of the University of Texas System expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/485, A61K31/515, A61K31/5513, A61K38/00